We were able to consistently amplify human TET2 DNA in tissue obtained from injected femurs, as well as noninjected femurs, spleens, and other organs showing evidence of AML infiltration, yielding 55 individual samples (32 from VC-treated mice and 23 from 5′-Aza–treated mice). Here, TET2 is linked to acute myeloid leukemia.